Ibnsina Pharma has increased its issued capital to EGP 205 mn from EGP 180.5 mn by issuing EGP 24.5 mn-worth of bonus shares, according to an EGX disclosure (pdf).
More from Enterprise
Farmers aren’t borrowing to survive anymore — they’re investing
Medium-term loans rose more than 1k% to EGP 22.6 bn…
Global FDI rises in 2025, but recovery is skewed toward developed economies — and importantly, AI
Developed economies lead the upswing, while developing economies see modest…
NowPay lands in KSA with USD 20 mn JV with Tas’heel
KSA is witnessing “accelerating demand for modern payroll, HR, and…